This book investigates pharmaceutical regulation and the public health issue of fake or illicit medicines in developing countries. Drawing on extensive fieldwork in India, Kenya and Europe, it analyses the evolution of pharmaceutical capitalism, showing how the entanglement of market and health interests has shaped global regulation.